Director Lakhmir S Chawla Acquires Common Stock in Revelation Biosciences, Inc.

On October 29, 2025, Lakhmir S Chawla, a director of Revelation Biosciences, Inc., acquired 15,625 shares of common stock at a price of $1.28 per share. This transaction was part of a restricted stock grant under the 2021 Equity Incentive Plan, which vests 100% on January 28, 2026. Following this transaction, Chawla owns a total of 15,686 shares of common stock. The acquisition was reported in a Form 4 filing with the SEC, signed by J.P. Galda as attorney-in-fact for Lakhmir S Chawla.